230 related articles for article (PubMed ID: 32772850)
1. Efficacy and safety of intravitreal dexamethasone implant in treatment naïve eyes with diabetic macular edema: Real world experience.
Ratra D; Sharma U; Dalan D
Eur J Ophthalmol; 2021 Jul; 31(4):1899-1906. PubMed ID: 32772850
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
[TBL] [Abstract][Full Text] [Related]
3. Pro Re Nata Dexamethasone Implant for Treatment-Naive Phakic Eyes with Diabetic Macular Edema: A Prospective Study.
Bilgic A; Sudhalkar A; Kodjikian L; Vasavada V; Vasavada S; Bhojwani D; Vasavada V; Srivastava S
Ophthalmol Retina; 2019 Nov; 3(11):929-937. PubMed ID: 31395504
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
Esen E; Sizmaz S; Demircan N
Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412
[TBL] [Abstract][Full Text] [Related]
5. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone implant in diabetic macular edema in real-life situations.
Chhablani J; Bansal P; Veritti D; Sambhana S; Sarao V; Pichi F; Carrai P; Massaro D; Lembo A; Mansour AM; Banker A; Gupta SR; Hamam R; Lanzetta P
Eye (Lond); 2016 Mar; 30(3):426-30. PubMed ID: 26611849
[TBL] [Abstract][Full Text] [Related]
7. Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema.
Wang JK; Huang TL; Chang PY
J Formos Med Assoc; 2020 Nov; 119(11):1619-1625. PubMed ID: 32482606
[TBL] [Abstract][Full Text] [Related]
8. DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.
Iglicki M; Busch C; Zur D; Okada M; Mariussi M; Chhablani JK; Cebeci Z; Fraser-Bell S; Chaikitmongkol V; Couturier A; Giancipoli E; Lupidi M; Rodríguez-Valdés PJ; Rehak M; Fung AT; Goldstein M; Loewenstein A
Retina; 2019 Jan; 39(1):44-51. PubMed ID: 29697589
[TBL] [Abstract][Full Text] [Related]
9. Short-term outcomes of intravitreal dexamethasone in relation to biomarkers in diabetic macular edema.
Narnaware SH; Bawankule PK; Raje D
Eur J Ophthalmol; 2021 May; 31(3):1185-1191. PubMed ID: 32429696
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
Mahapatra SK; Kumari S
Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010
[TBL] [Abstract][Full Text] [Related]
12. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.
Mathis T; Lereuil T; Abukashabah A; Voirin N; Sudhalkar A; Bilgic A; Denis P; Dot C; Kodjikian L
Acta Diabetol; 2020 Dec; 57(12):1413-1421. PubMed ID: 32656710
[TBL] [Abstract][Full Text] [Related]
14. Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function.
Minnella AM; Maceroni M; Picardi SM; Placidi G; De Siena E; Rizzo S; Falsini B
Adv Ther; 2020 Nov; 37(11):4675-4684. PubMed ID: 32970316
[TBL] [Abstract][Full Text] [Related]
15. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
[TBL] [Abstract][Full Text] [Related]
16. Results of dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema patients: Early versus late switch.
Ruiz-Medrano J; Rodríguez-Leor R; Almazán E; Lugo F; Casado-Lopez E; Arias L; Ruiz-Moreno JM
Eur J Ophthalmol; 2021 May; 31(3):1135-1145. PubMed ID: 32493065
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience.
Mello Filho P; Andrade G; Maia A; Maia M; Biccas Neto L; Muralha Neto A; Moura Brasil O; Minelli E; Dalloul C; Iglicki M
Ophthalmologica; 2019; 241(1):9-16. PubMed ID: 30408801
[TBL] [Abstract][Full Text] [Related]
19. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
[TBL] [Abstract][Full Text] [Related]
20. Results of intravitreal dexamethasone implant (Ozurdex®) for retinal vascular diseases with macular edema: An observational study of real-life situations.
Jirarattanasopa P; Jiranoppasakdawong S; Ratanasukon M; Bhurayanontachai P; Dangboon W
Medicine (Baltimore); 2022 Jul; 101(27):e29807. PubMed ID: 35801769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
